- Home
- ACMR vs ZLAB Comparison
ACMR vs ZLAB Comparison
Compare ACMR & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACMR
- ZLAB
- Stock Information
- Founded
- ACMR 1998
- ZLAB 2013
- Country
- ACMR United States
- ZLAB China
- Employees
- ACMR N/A
- ZLAB N/A
- Industry
- ACMR Industrial Machinery/Components
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- ACMR Technology
- ZLAB Health Care
- Exchange
- ACMR Nasdaq
- ZLAB Nasdaq
- Market Cap
- ACMR 2.5B
- ZLAB 2.2B
- IPO Year
- ACMR 2017
- ZLAB 2017
- Fundamental
- Price
- ACMR $33.09
- ZLAB $19.88
- Analyst Decision
- ACMR Buy
- ZLAB Buy
- Analyst Count
- ACMR 4
- ZLAB 6
- Target Price
- ACMR $34.67
- ZLAB $57.22
- AVG Volume (30 Days)
- ACMR 1.5M
- ZLAB 931.8K
- Earning Date
- ACMR 11-05-2025
- ZLAB 11-06-2025
- Dividend Yield
- ACMR N/A
- ZLAB N/A
- EPS Growth
- ACMR 29.16
- ZLAB N/A
- EPS
- ACMR 1.72
- ZLAB N/A
- Revenue
- ACMR $880,350,000.00
- ZLAB $441,629,000.00
- Revenue This Year
- ACMR $18.90
- ZLAB $40.71
- Revenue Next Year
- ACMR $16.78
- ZLAB $50.42
- P/E Ratio
- ACMR $19.21
- ZLAB N/A
- Revenue Growth
- ACMR 20.77
- ZLAB 24.14
- 52 Week Low
- ACMR $13.87
- ZLAB $19.51
- 52 Week High
- ACMR $45.12
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- ACMR 46.37
- ZLAB 18.64
- Support Level
- ACMR $28.46
- ZLAB $19.51
- Resistance Level
- ACMR $32.78
- ZLAB $20.29
- Average True Range (ATR)
- ACMR 1.93
- ZLAB 0.76
- MACD
- ACMR -0.06
- ZLAB 0.02
- Stochastic Oscillator
- ACMR 78.80
- ZLAB 7.44
About ACMR ACM Research Inc.
ACM Research Inc supplies advanced, innovative capital equipment developed for the world-wide semiconductor industry. Fabricators of advanced integrated circuits, or chips, can use its wet-cleaning and other front-end processing tools in numerous steps to improve product yield, even at increasingly advanced process nodes. It has designed these tools for use in fabricating foundry, logic and memory chips, including dynamic random-access memory, or DRAM, and 3D NAND-flash memory chips. The company also develops, manufactures and sells advanced packaging tools to wafer assembly and packaging customers.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.